(Q37139484)

18 August 2017

1 reference

title

Apoprotein A-V: an important regulator of triglyceride metabolism (English)

1 reference

18 August 2017

1 reference

M Kluger

1

1 reference

18 August 2017

J Heeren

series ordinal

2

1 reference

18 August 2017

M Merkel

series ordinal

3

1 reference

18 August 2017

publication date

14 April 2008

1 reference

Journal of Inherited Metabolic Disease

18 August 2017

published in

1 reference

18 August 2017

volume

31

1 reference

18 August 2017

issue

2

1 reference

18 August 2017

page(s)

281-288

1 reference

https://scigraph.springernature.com/pub.10.1007/s10545-008-0863-4

18 August 2017

exact match

0 references

cites work

Apolipoprotein A5, a crucial determinant of plasma triglyceride levels, is highly responsive to peroxisome proliferator-activated receptor alpha activators

1 reference

12 December 2020

Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment

1 reference

12 December 2020

Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5

1 reference

12 December 2020

A polymorphism in the apolipoprotein A5 gene is associated with weight loss after short-term diet

1 reference

12 December 2020

Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease.

1 reference

12 December 2020

ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis

1 reference

12 December 2020

Newly identified loci that influence lipid concentrations and risk of coronary artery disease

1 reference

12 December 2020

Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration

1 reference

12 December 2020

Apolipoprotein A-V-heparin interactions: implications for plasma lipoprotein metabolism

1 reference

12 December 2020

The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II.

1 reference

12 December 2020

A sandwich enzyme-linked immunosorbent assay for human plasma apolipoprotein A-V concentration

1 reference

12 December 2020

APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FERHDL but is not a risk factor for coronary artery disease

1 reference

12 December 2020

Lipolysis of very low density lipoproteins by heparan sulfate proteoglycan-bound lipoprotein lipase

1 reference

12 December 2020

Association between DNA variant sites in the apolipoprotein A5 gene and coronary heart disease in Chinese

1 reference

12 December 2020

The APOA5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in Singapore

1 reference

12 December 2020

Genetic variations of apolipoprotein A5 gene is associated with the risk of coronary artery disease among Chinese in Taiwan

1 reference

12 December 2020

Receptors for triglyceride-rich lipoproteins and their role in lipoprotein metabolism.

1 reference

12 December 2020

Apolipoprotein A-V interaction with members of the low density lipoprotein receptor gene family

1 reference

12 December 2020

SNPs at the APOA5 gene account for the strong association with hypertriglyceridaemia at the APOA5/A4/C3/A1 locus on chromosome 11q23 in the Northern Irish population

1 reference

12 December 2020

Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase.

1 reference

12 December 2020

Rare APOA5 mutations--clinical consequences, metabolic and functional effects: an ENID review

1 reference

12 December 2020

A novel sequence variant in APOA5 gene found in patients with severe hypertriglyceridemia

1 reference

12 December 2020

Give me A5 for lipoprotein hydrolysis!

1 reference

12 December 2020

Evidence for a complex relationship between apoA-V and apoC-III in patients with severe hypertriglyceridemia

1 reference

12 December 2020

Genetic risk for metabolic syndrome: examination of candidate gene polymorphisms related to lipid metabolism in Japanese people.

1 reference

12 December 2020

Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study

1 reference

12 December 2020

In vivo characterization of human APOA5 haplotypes

1 reference

12 December 2020

Apolipoprotein A5 gene promoter region T-1131C polymorphism associates with elevated circulating triglyceride levels and confers susceptibility for development of ischemic stroke.

1 reference

12 December 2020

The single nucleotide polymorphism -1131T>C in the apolipoprotein A5 (APOA5) gene is associated with elevated triglycerides in patients with hyperlipidemia

1 reference

12 December 2020

Linkage and association between distinct variants of the APOA1/C3/A4/A5 gene cluster and familial combined hyperlipidemia

1 reference

12 December 2020

The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins

1 reference

12 December 2020

Association of human serum apolipoprotein A5 with lipid profiles affected by gender.

1 reference

12 December 2020

Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism

1 reference

12 December 2020

Variants at the APOA5 locus, association with carotid atherosclerosis, and modification by obesity: the Framingham Study.

1 reference

12 December 2020

Structure and interfacial properties of human apolipoprotein A-V

1 reference

12 December 2020

Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles

1 reference

12 December 2020

Haplotype analysis of the apolipoprotein gene cluster on human chromosome 11.

1 reference

12 December 2020

Triglyceride associated polymorphisms of the APOA5 gene have very different allele frequencies in Pune, India compared to Europeans

1 reference

12 December 2020

APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease: results from the LOCAT study

1 reference

12 December 2020

Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia

1 reference

12 December 2020

Determination of the functionality of common APOA5 polymorphisms

1 reference

12 December 2020

A genetic variant c.553G > T in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and altered triglyceride levels in a Chinese population

1 reference

12 December 2020

Apolipoprotein A5 T-1131C variant confers risk for metabolic syndrome

1 reference

12 December 2020

Apolipoprotein A-V, triglycerides and risk of coronary artery disease: the prospective Epic-Norfolk Population Study

1 reference

12 December 2020

Recycling of apolipoprotein E and lipoprotein lipase through endosomal compartments in vivo.

1 reference

12 December 2020

Plasma apolipoprotein A5 and triglycerides in type 2 diabetes

1 reference

12 December 2020

Newly identified apolipoprotein AV gene predisposes to high plasma triglycerides in familial combined hyperlipidemia

1 reference

12 December 2020

Relationship of apolipoprotein A5 and apolipoprotein C3 levels to serum triglycerides in patients with type 2 diabetes

1 reference

12 December 2020

APOC3/A5 haplotypes, lipid levels, and risk of myocardial infarction in the Central Valley of Costa Rica

1 reference

12 December 2020

Structure-function studies of human apolipoprotein A-V: a regulator of plasma lipid homeostasis

1 reference

12 December 2020

APOA5 gene variation modulates the effects of dietary fat intake on body mass index and obesity risk in the Framingham Heart Study

1 reference

12 December 2020

Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN study.

1 reference

12 December 2020

Impact of APOA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men.

1 reference

12 December 2020

A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia

1 reference

12 December 2020

Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels

1 reference

12 December 2020

An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing

1 reference

12 December 2020

APOA5polymorphisms influence plasma triglycerides in young, healthy African Americans and whites of the CARDIA Study

1 reference

12 December 2020

Analysis of apolipoprotein A5, c3, and plasma triglyceride concentrations in genetically engineered mice

1 reference

12 December 2020

APOA5 variants and metabolic syndrome in Caucasians.

1 reference

12 December 2020

Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia

1 reference

12 December 2020

Apolipoprotein A5, a newly identified gene that affects plasma triglyceride levels in humans and mice

1 reference

12 December 2020

10.1007/S10545-008-0863-4

Identifiers

DOI

1 reference

18 August 2017

1 reference